Role of protein tyrosine phosphatases in the regulation of interferon-γ-induced macrophage nitric oxide generation: Implication of ERK pathway and AP-1 activation

Journal of Leukocyte Biology

Volumn 81, Issue 3, 2007, Pages 835-844

  Blanchette, Julie ^a   Pouliot, Philippe ^b   Olivier, Martin ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Peroxovanadiums; Protein tyrosine kinases; Second messengers; Transcription factors

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; RAPAMYCIN; SALICYLATE SODIUM; STAT PROTEIN; STAT1 PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; LEISHMANIA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERFERON TYPE II; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORGANOMETALLIC COMPOUNDS; PHENANTHROLINES; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; SIROLIMUS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR AP-1;

MURINAE;

EID: 33847788947     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0505252     Document Type: Article

References (64)

1. Lowenstein, C. J., Snyder, S. H. (1992) Nitric oxide, a novel biologic messenger. Cell 70, 705-707.
2. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
3. Palmer, R. M., Ferrige, A. G., Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
4. Radomski, M. W., Palmer, R. M., Moncada, S. (1987) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92, 639-646.
5. Garthwaite, J. (1991) Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14, 60-67.
6. Green, S. J., Nacy, C. A., Meltzer, M. S. (1991) Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50, 93-103.
7. Liew, F. Y. (1993) The role of nitric oxide in parasitic diseases. Ann. Trop. Med. Parasitol. 87, 637-642.
8. Lowenstein, C. J., Dinerman, J. L., Snyder, S. H. (1994) Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120, 227-237.
9. Croen, K. D. (1993) Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91, 2446-2452.
10. Karupiah, G., Xie, Q. W., Buller, R. M., Nathan, C., Duarte, C., MacMicking, J. D. (1993) Inhibition of viral replication by interferon-γ- induced nitric oxide synthase. Science 261, 1445-1448.
11. Hibbs Jr., J. B., Taintor, R. R., Vavrin, Z., Rachlin, E. M. (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157, 87-94.
12. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., Snyder, S. H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714-718.
13. Lamas, S., Marsden, P. A., Li, G. K., Tempst, P., Michel, T. (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 89, 6348-6352.
14. Bogdan, C., Rollinghoff, M., Diefenbach, A. (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12, 64-76.
15. Lowenstein, C. J., Glatt, C. S., Bredt, D. S., Snyder, S. H. (1992) Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89, 6711-6715.
16. Lyons, C. R., Orloff, G. J., Cunningham, J. M. (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267, 6370-6374.
17. Bredt, D. S., Snyder, S. H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685.
18. Busse, R., Mulsch, A. (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265, 133-136.
19. Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D., Wishnok, J. S. (1988) Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27, 8706-8711.
20. Nathan, C., Xie, Q. W. (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-918.
21. Xie, Q. W., Cho, H., Kashiwabara, Y., Baum, M., Weidner, J. R., Elliston, K., Mumford, R., Nathan, C. (1994) Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity. J. Biol. Chem. 269, 28500-28505.
22. Bogdan, C., Rollinghoff, M., Diefenbach, A. (2000) The role of nitric oxide in innate immunity. Immunol. Rev. 173, 17-26.
23. Forget, G., Siminovitch, K. A., Brochu, S., Rivest, S., Radzioch, D., Olivier, M. (2001) Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31, 3185-3196.
24. Matte, C., Marquis, J. F., Blanchette, J., Gros, P., Faure, R., Posner, B. I., Olivier, M. (2000) Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur. J. Immunol. 30, 2555-2564.
25. Proudfoot, L., Nikolaev, A. V., Feng, G. J., Wei, W. Q., Ferguson, M. A., Brimacombe, J. S., Liew, F. Y. (1996) Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA 93, 10984-10989.
26. Blanchette, J., Racette, N., Faure, R., Siminovitch, K. A., Olivier, M. (1999) Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-γ-triggered JAK2 activation. Eur. J. Immunol. 29, 3737-3744.
27. Nandan, D., Reiner, N. E. (1995) Attenuation of γ interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect. Immun. 63, 4495-4500.
28. Olivier, M., Romero-Gallo, B. J., Matte, C., Blanchette, J., Posner, B. I., Tremblay, M. J., Faure, R. (1998) Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression. J. Biol. Chem. 273, 13944-13949.
29. Olivier, M., Gregory, D. J., Forget, G. (2005) Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18, 293-305.
30. Posner, B. I., Faure, R., Burgess, J. W., Bevan, A. P., Lachance, D., Zhang-Sun, G., Fantus, I. G., Ng, J. B., Hall, D. A., Lum, B. S. (1994) Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 269, 4596-4604.
31. Bevan, A. P., Burgess, J. W., Yale, J. F., Drake, P. G., Lachance, D., Baquiran, G., Shaver, A., Posner, B. I. (1995) In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency. Am. J. Physiol. 268, E60-E66.
32. Faure, R., Vincent, M., Dufour, M., Shaver, A., Posner, B. I. (1995) Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line. J. Cell. Biochem. 59, 389-401.
33. Barbeau, B., Bernier, R., Dumais, N., Briand, G., Olivier, M., Faure, R., Posner, B. I., Tremblay, M. (1997) Activation of HIV-1 long terminal repeat transcription and virus replication via NF-κB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J. Biol. Chem. 272, 12968-12977.
34. Gao, J., Morrison, D. C., Parmely, T. J., Russell, S. W., Murphy, W. J. (1997) An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J. Biol. Chem. 272, 1226-1230.
35. Bhat, N. R., Zhang, P., Lee, J. C., Hogan, E. L. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
36. Blanchette, J., Jaramillo, M., Olivier, M. (2003) Signaling events involved in interferon-γ-inducible macrophage nitric oxide generation. Immunology 108, 513-522.
37. Caivano, M. (1998) Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett. 429, 249-253.
38. Chan, E. D., Winston, B. W., Uh, S. T., Wynes, M. W., Rose, D. M., Riches, D. W. (1999) Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 162, 415-422.
39. Band, C. J., Posner, B. I. (1997) Phosphatidylinositol 3′-kinase and p70s6k are required for insulin but not bisperoxovanadium 1,10-phenanthroline (bpV(phen)) inhibition of insulin-like growth factor binding protein gene expression. Evidence for MEK-independent activation of mitogen-activated protein kinase by bpV(phen). J. Biol. Chem. 272, 138-145.
40. Kim, Y. M., Lee, B. S., Yi, K. Y., Paik, S. G. (1997) Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-γ plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 236, 655-660.
41. Nathan, C., Xie, Q. W. (1994) Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269, 13725-13728.
42. Xie, Q. W., Kashiwabara, Y., Nathan, C. (1994) Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
43. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
44. Salh, B., Wagey, R., Marotta, A., Tao, J. S., Pelech, S. (1998) Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J. Immunol. 161, 6947-6954.
45. Bogdan, C. (2001) Nitric oxide and the immune response. Nat. Immunol. 2, 907-916.
46. Taylor, B. S., Liu, S., Villavicencio, R. T., Ganster, R. W., Geller, D. A. (1999) The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte. Hepatology 29, 1199-1207.
47. Zheng, X. L., Gui, Y., Sharkey, K. A., Hollenberg, M. D. (1999) Differential induction of nitric oxide synthase in rat gastric and vascular smooth muscle tissue: distinct tissue distribution and distinctive signaling pathways. J. Pharmacol. Exp. Ther. 289, 632-640.
48. Diaz-Guerra, M. J., Castrillo A., Martin-Sanz P., Bosca L. (1999) Negative regulation by protein tyrosine phosphatase of IFN-γ-dependent expression of inducible nitric oxide synthase. J. Immunol. 162, 6776-6783.
49. Pan, J., Burgher, K. L., Szczepanik, A. M., Ringheim, G. E. (1996) Tyrosine phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem. J. 314, 889-894.
50. Band, C. J., Posner, B. I., Dumas, V., Contreres, J. O. (1997) Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen). Mol. Endocrinol. 11, 1899-1910.
51. Krady, M. M., Freyermuth, S., Rogue, P., Malviya, A. N. (1997) Pervanadate elicits proliferation and mediates activation of mitogen-activated protein (MAP) kinase in the nucleus. FEBS Lett. 412, 420-424.
52. Krady, M. M., Malviya, A. N., Dupont, J. L. (1998) Pervanadate-triggered MAP kinase activation and cell proliferation are not sensitive to PD 98059. Evidence for stimulus-dependent differential PD 98059 inhibition mechanism. FEBS Lett. 434, 241-244.
53. Zhao, Z., Tan, Z., Diltz, C. D., You, M., Fischer, E. H. (1996) Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J. Biol. Chem. 271, 22251-22255.
54. Daum, G., Kalmes, A., Levkau, B., Wang, Y., Davies, M. G., Clowes, A. W. (1998) Pervanadate inhibits mitogen-activated protein kinase kinase-1 in a p38MAPK-dependent manner. FEBS Lett. 427, 271-274.
55. Rumora, L., Shaver, A., Zanic-Grubisic, T., Maysinger, D. (2001) Differential regulation of JNK activation and MKP-1 expression by peroxovanadium complexes. Neurochem. Int. 38, 341-347.
56. Chan, E. D., Riches, D. W. (2001) IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol. 280, C441-C450.
57. Faure, V., Hecquet, C., Courtois, Y., Goureau, O. (1999) Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells. J. Biol. Chem. 274, 4794-4800.
58. Attur, M. G., Patel, R., Thakker, G., Vyas, P., Levartovsky, D., Patel, P., Naqvi, S., Raza, R., Patel, K., Abramson, D., Amin, A. R. (2000) Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm. Res. 49, 20-26.
59. Moncada, S., Higgs, E. A. (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9, 1319-1330.
60. Xie, Q. W., Nathan, C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. Trans. Assoc. Am. Physicians 106, 1-12.
61. Rosenberger, S. F., Finch, J. S., Gupta, A., Bowden, G. T. (1999) Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation. J. Biol. Chem. 274, 1124-1130.
62. Biggs, T. E., Cooke, S. J., Barton, C. H., Harris, M. P., Saksela, K., Mann, D. A. (1999) Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events. J. Mol. Biol. 290, 21-35.
63. Campa, V. M., Iglesias, J. M., Carcedo, M. T., Rodriguez, R., Riera, J., Ramos, S., Lazo, P. S. (2005) Polyinosinic acid induces TNF and NO production as well as NF-κB and AP-1 transcriptional activation in the monocytemacrophage cell line RAW 264.7. Inflamm. Res. 54, 328-337.
64. Jang, J. H., Surh, Y. J. (2005) AP-1 mediates β-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways. Biochem. Biophys. Res. Commun. 331, 1421-1428.